In vitro sustained drug release of large-pore calcium phosphate cement and chitosan microsphere ;composites
Shujiang Zhang,Yifeng Li,Yi Chen,Bo Bai,Yongchang Yao,Dongyang Qian,Xuetao Shi,Ying Wang
DOI: https://doi.org/10.3877/cma.j.issn.1674-134X.2016.06.009
2016-01-01
Abstract:Objective To construct a large-pore scaffold of calcium phosphates cement ( CP) as drug controlled release carrier with ability of inducing osteogenesis .Methods The vancomycin-chitosan microspheres were prepared by emulsion chemical crosslink method , and the drug loading efficiency was determined.The different amount ( 2 mg, 6 mg, 10 mg as three groups ) of vancomycin-chitosan microspheres were mixed with CPC to make the large-pore CPC composites; the drug releasing curve was determined and five time points (0 h, 8 h, 72 h, 168 h, 216 h) were chosen to compare the drug releasing concentration of the three groups .The elastic modulus was determined and compared among the large-pore CPC composites with different amount of chitosan microspheres (0 mg, 2 mg, 6 mg, 10 mg).The data were analyzed by one-way ANOVA.Results The drug loading efficiency of chitosan microspheres was 30.6%;the elastic modulus of large-pore CPC composites with different amount of chitosan spheres showed no significant difference ( P>0.05 ) .The CPC composites with different amount of chitosan spheres all presented stable and slow drug releasing curves .The drug releasing concentration of the three groups at 0 h, 8 h,72 h, 168 h showed significant differences among the groups ( F=234.91, 7171.27, 1161569, 60.5, P<0.05), while at 216h the differences of the three groups were not significant (P>0.05).The group of 6mg presented significant differences in drug releasing concentration at 0h, 8h,72h, 168h compare with the groups of 2mg and 6mg (all P<0.05).Conclusion The composites of vancomycin-chitosan microshperes and large-pore CPC has a stable and effective drug controlled release ability , and the chitosan microspheres show little influence on the mechanical property of CPC , which might be a potential drug controlled release carrier for bone defection with infection .